Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma (AMEP)

This study has been terminated.
(The study has been halted due to the low enrolment rate.)
Sponsor:
Information provided by (Responsible Party):
Onxeo
ClinicalTrials.gov Identifier:
NCT01045915
First received: January 8, 2010
Last updated: September 10, 2015
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2013
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)